Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) Completed Phase 3 Trials for Coronary Artery Disease Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02522481Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
NCT02552238Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142